Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions

European Journal of Pharmacology

Volumn 685, Issue 1-3, 2012, Pages 1-7

  Karroum, Asmae ^a   Mirshahi, Pezhman ^a   Faussat, Anne Marie ^b   Therwath, Amu ^a   Mirshahi, Massoud ^a   Hatmi, Mohamed ^a,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b IFR 65   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

Breast cancer cells MCF 7; MDR1 phenotype; MMP 9; Tubular network; VEGFR 2 VEGFR 3 receptor subtype

Indexed keywords

BEVACIZUMAB; DOXORUBICIN; GELATINASE B; PHORBOL 13 ACETATE 12 MYRISTATE; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ARTICLE; BREAST ADENOCARCINOMA; BREAST EPITHELIUM; CANCER GROWTH; CANCER RESISTANCE; CELL DENSITY; CELL MIGRATION; CELL STRAIN MCF 7; COMPLEX FORMATION; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL, HUMANIZED; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; TETRADECANOYLPHORBOL ACETATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84861339074     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.04.004     Document Type: Article

References (49)

1. R. Aesoy, B.C. Sanchez, J.H. Norum, R. Lewensohn, K. Viktorsson, and B. Linderholm An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells Mol. Cancer Res. 6 2008 1630 1638
2. G.-O. Ahn, and J.M. Brown Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells Cancer Cell 13 2008 193 205
3. M. Akahane, T. Akahane, A. Shah, E. Okajima, and U.P. Thorgeirsson A potential role for vascular endothelial growth factor-D as an autocrine growth for human breast carcinoma cells Anticancer Res. 25 2005 701 708
4. S.V. Ambudkar, C. Kimchi-Sarfaty, Z.E. Sauna, and M.M. Gottesman P-glycoprotein: from genomics to mechanism Oncogene 22 2003 7468 7485
5. G. Arancia, A. Molinari, A. Calcabrini, S. Meschini, and M. Cianfriglia Intracellular P-glycoprotein in multidrug resistant tumor cells Ital. J. Anat. Embryol. 108 2001 59 68
6. G.D. Basu, W.S. Liang, D.A. Stephan, L.T. Wegener, C.R. Conley, B.A. Pockai, and P. Mukherjee A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells Breast Cancer Res. 8 2006 R69
7. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat. Rev. Cancer 3 2003 401 410
8. J.W. Breslin, M.H. Wu, and S.Y. Yuan VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism Lymphat. Res. Biol. 5 2007 105 113
9. J.P. Dales, S. Garcia, P. Bonnier, F. Duffaud, S. Carpentier, A. Djemli, O. Ramuz, L. Andrac, M. Lavaut, C. Allasia, and C. Charpin Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma Ann. Pathol. 23 2003 297 305
10. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev. Cancer 2 2002 161 174
11. N. Ferrara, and T. Davis-Smyth The biology of vascular endothelial growth factor Endocr. Rev. 18 1997 4 25
12. N. Ferrara, H.-P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 2003 669 675
13. N. Ferrara, K.J. Hillan, and W. Novotny Bevacizumab (Avastin) a humanized anti-VEGF monoclonal antibody for cancer therapy Biochem. Biophys. Res. Commun. 333 2005 328 335
14. R. Folberg, and A.J. Maniotis Vasculogenic mimicry APMIS 112 2004 508 525
15. J. Folkman Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285 1971 1182 1186
16. J. Folkman Role of angiogenesis in tumor growth and metastasis Semin. Oncol. 29 2002 15 18
17. J. Gao, Z.Y. Liu, W. Wang, Y.S. Bi, and H. Tian Expression of vascular endothelial growth factor C in human breast cancer cell lines MCF-7 and MCF-7/Adr Ai Zheng 21 2002 163 166
18. Y.-L. Ge, X. Zhang, J.-Y. Zhang, L. Hou, and R.-H. Tian The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells Int. Immunopharmacol. 9 2009 389 395
19. S. Guo, L.S. Colbert, M. Filler, Y. Zhang, and R. Gonzales-Perez Vascular endothelial growth factor-2 in breast cancer Biochim. Biophys. Acta 1806 2010 108 121
20. M.J. Hendrix, E.A. Seftor, P.S. Meltzer, L.M. Gardner, A.R. Hess, D.A. Kirschmann, G.C. Schatteman, and R.E. Seftor Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry Proc. Natl. Acad. Sci. U. S. A. 98 2001 8018 8023
21. K.J. Higgins, S. Liu, M. Abdelrahim, K. Vanderlaag, X. Liu, W. Porter, R. Metz, and S. Safe Vascular endothelial growth factor receptor-2 expression is down-regulated by 17 beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins Mol. Endocrinol. 22 2008 388 402
22. P.H. Huang, Y.H. Chen, C.H. Wang, J.S. Chen, H.Y. Tsai, F.Y. Lin, W.Y. Lo, T.C. Wu, M. Sata, J.W. Chen, and S.J. Lin Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells Arterioscler. Thromb. Vasc. Biol. 29 2009 1179 1184
23. N. Imai, M. Shikami, H. Miwa, K. Suganuma, A. Hiramatsu, M. Watarai, A. Satoh, M. Itoh, A. Imamura, H. Mihara, and M. Nitta T(8; 21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type 2 pathway and phosphorylation of AKt Br. J. Haematol. 135 2006 673 682
24. A. Karroum, P. Mirshahi, N. Benabbou, A.-M. Faussat, J. Soria, A. Therwath, M. Mirshahi, and M. Hatmi Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways Cancer Lett. 295 2010 242 251
25. S.P. Khosravi, and P.I. Fernandez Tumoral angiogenesis: review of the literature Cancer Invest. 26 2008 104 108
26. H.M. Kluger, S.F. Siddiqui, C. Angeletti, M. Sznol, W.K. Kelly, A.M. Molinaro, and R.L. Camp Classification of renal cell carcinoma based on expression of VEGF and VEGF receptors in both tumor cells and endothelial cells Lab. Invest. 88 2008 962 972
27. Q.Q. Li, W.J. Wang, J.D. Xu, X.X. Cao, Q. Chen, J.M. Yang, and Z.D. Xu Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells Cancer Sci. 98 2007 1767 1774
28. B. Liu, H.M. Earl, D. Baban, M. Shoaibi, A. Fabra, D.J. Kerr, and L.W. Seymour Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF Biochem. Biophys. Res. Commun. 217 1995 721 727
29. A.J. Maniotis, R. Folberg, A. Hess, E.A. Seftor, L.M. Gardner, J. Peer, J.M. Trent, P.S. Meltzer, and M.J. Hendrix Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry Am. J. Pathol. 155 1999 739 752
30. P. Mirshahi, A. Rafii, A. Berthaut, R. Varin, G. Kalantar, C. Marzac, O.A. Calandini, J.-P. Marie, C. Soria, J. Soria, and M. Mirshahi Vasculogenic mimicry of acute leukemic bone marrow stromal cells Leukemia 23 2009 1039 1048
31. O.R. Mook, W.M. Frederiks, and C.J. Van Noorden The role of gelatinases in colorectal cancer progression and metastasis Biochim. Biophys. Acta 1705 2004 69 89
32. L. Nakopoulou, K. Stefanaki, E. Panayotopoulou, I. Giannopoulou, P. Athanassiadou, H. Gakiopoulou-Givalou, and A. Louvrou Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinoma: correlation with proliferation Hum. Pathol. 33 2002 863 870
33. I. Nilsson, F. Bahram, X. Li, L. Gualandi, S. Koch, M. Jarvius, O. Söderberg, A. Anisimov, I. Kholova, B. Pytowski, M. Baldwin, S. Ylä-Herttuala, K. Alitalo, J. Kreuger, and L. Claesson-Welsh VEGF receptor-2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts EMBO J. 29 2010 1377 1388
34. C. Overall, and C. Lopez-Otin Strategies for MMP inhibition in cancer: innovations for the post-trial era Nat. Rev. Cancer 2 2002 657 672
35. Y.W.J. Paulis, P.M.M.B. Soetekouw, H.M.W. Verheul, V.C.G. Tjan-Heijnen, and A.W. Griffioen Signalling pathways in vasculogenic mimicry Biochim. Biophys. Acta 1806 2010 18 28
36. T.V. Petrova, P. Bono, W. Holnthoner, J. Chesnes, B. Pytowski, H. Sihto, P. Laakkonen, P. Heikkilä, H. Joensuu, and K. Alitalo VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors Cancer Cell 13 2008 554 556
37. D.J. Price, T. Miralem, S. Jiang, R. Steinberg, and H. Avraham Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells Cell Growth Differ. 12 2001 129 135
38. R. Roskoski Vascular endothelial growth factor (VEGF) signalling in tumor progression Crit. Rev. Oncol. Hematol. 62 2007 179 213
39. A.M. Scherbakov, Y.S. Lobanova, V.A. Shatskaya, O.V. Onopchenko, E.S. Gershtein, and M.A. Krasil'nikov Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells Breast Cancer Res. Treat. 100 2006 1 11
40. S.A. Stacker, R.A. Hughes, R.A. Williams, and M.G. Achen Current strategies for modulating lymphangiogenesis signalling pathways in human disease Curr. Med. Chem. 13 2006 783 792
41. I. Stamenkovic Matrix metalloproteinases in tumour invasion and metastasis Semin. Cancer Biol. 10 2000 415 433
42. L.J. Su, P.C. Yang, J.Y. Shih, C.Y. Yang, L.H. Wei, C.Y. Hsieh, C.H. Chou, Y.M. Jeng, M.Y. Wang, K.J. Chang, M.C. Hung, and M.L. Kuo The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells Cancer Cell 9 2006 209 223
43. D.W. van der Schaft, R.E. Seftor, E.A. Seftor, A.R. Hess, L.M. Grunman, D.A. Kirschmann, Y. Yokoyama, A.W. Griffioen, and M.J. Hendrix Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells J. Natl. Cancer Inst. 96 2004 1473 1477
44. N. Walsh, A. Larkin, S. Kennedy, L. Connolly, J. Ballot, W. Ooi, G. Gullo, J. Crown, M. Clynes, and L. O'Driscoll Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma BMC Urol. 2009 10.1186/1471-2490-9-6
45. W. Wu, X. Shu, H. Hovsepyan, R.D. Mosteller, and D. Broek VEGF receptor expression and signaling in human bladder tumors Oncogene 22 2003 3361 3370
46. P. Wülfing, C. Kersting, H. Buerger, B. Wattsson, R. Mesters, C. Gustmann, B. Hinrichs, J. Tio, W. Böcker, and L. Kiesel Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ Br. J. Cancer 92 2005 1720 1728
47. J.-M. Yang, Z. Xu, H. Wu, H. Zhu, X. Wu, and W.N. Hait Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells Mol. Cancer Res. 1 2003 420 427
48. S. Zhang, D. Zhang, and B. Sun Vasculogenic mimicry: current status and future prospects Cancer Lett. 254 2007 157 164
49. H. Zheng, H. Takahashi, Y. Murai, Z. Cui, K. Nomoto, H. Niwa, K. Tsuneyama, and Y. Takano Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma Anticancer Res. 26 2006 3579 3583